|
Volumn 535, Issue 7611, 2016, Pages S4-S6
|
Biomedicine: Move over, morphine
a
a
NONE
(Australia)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MORPHINE;
CYCLOPEPTIDE;
ENDOMORPHIN 1;
MORPHINE DERIVATIVE;
MU OPIATE RECEPTOR;
OLIGOPEPTIDE;
PHENOL DERIVATIVE;
TAPENTADOL;
TRAMADOL;
TYR-C(LYS-TRP-PHE-GLU)-GLY-NH2;
BIOTECHNOLOGY;
DISEASE TREATMENT;
DRUG;
ELECTRONIC EQUIPMENT;
INJURY;
INNOVATION;
ANALGESIA;
ARTICLE;
CHRONIC PAIN;
HUMAN;
PRESCRIPTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RISK ASSESSMENT;
ACUTE PAIN;
ADULT;
AGONISTS;
COMPLICATION;
DEVICES;
DRUG TOLERANCE;
EARLY INTERVENTION;
MALE;
METABOLISM;
NERVE CELL INHIBITION;
OPIOID-RELATED DISORDERS;
PROCEDURES;
PSYCHOLOGY;
SPINAL CORD STIMULATION;
YOUNG ADULT;
ACUTE PAIN;
ADULT;
CHRONIC PAIN;
DRUG TOLERANCE;
EARLY MEDICAL INTERVENTION;
HUMANS;
MALE;
MORPHINE;
MORPHINE DERIVATIVES;
NEURAL INHIBITION;
OLIGOPEPTIDES;
OPIOID-RELATED DISORDERS;
PAIN MANAGEMENT;
PEPTIDES, CYCLIC;
PHENOLS;
RECEPTORS, OPIOID, MU;
SPINAL CORD STIMULATION;
TRAMADOL;
YOUNG ADULT;
|
EID: 84978834479
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/535S4a Document Type: Article |
Times cited : (11)
|
References (3)
|